By Evan Vitale
What’s new in the fast-paced world of venture capital? Here are some recent headlines making news.
During the third quarter 2016, venture capital sentiment surges as tech IPOs pop, so says an online article by CNBC.
Start-up investors showed a jolt of optimism in the third quarter, thanks to some initial public offerings (IPOs), after a first half with none.
Confidence among venture investors jumped 8 percent in the period, the biggest increase since the first quarter of 2012, according to the Silicon Valley Venture Capitalist Confidence Index. Based on a 5-point scale, confidence rose to 3.88, from 3.6 in the second quarter, the report said.
The survey of 32 venture capitalists by Mark Cannice, a professor at the University of San Francisco School of Management, showed that while exit activity is still historically slow, there are reasons to be excited heading into the new year.
You are read the entire article here: http://cnb.cx/2e4XxEh
The Michigan Venture Capital Association recognized top tech innovators at its annual dinner recently.
Millendo Therapeutics, Fontinalis Partners and RetroSense Therapeutics were the top honorees Wednesday at the Michigan Venture Capital Association‘s 2016 Awards Dinner.
Ann Arbor-based Millendo Therapeutics works on finding drugs to improve the quality of life for patients with endocrine diseases. It won the Capital Event of the Year Award as the state’s largest health care deal in 2016 and largest venture capital financing round in the state.
The full article is here: http://bit.ly/2fHgb5K
In Cincinnati, Everything But The House has landed $41.5 million in its latest round of venture capital fundraising. EBTH’s “Series C” round of investment is expected to help the Downtown Cincinnati-based company grow its operations, build out technology platforms and expand its team nationally. Maryland-based Greenspring Associates led the latest round of investment in EBTH with participation from Greycroft Partners and Spark Capital.
Check out the article here for more details: http://cin.ci/2feMZ5x
